Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 26, 2017 (9 years ago)

0.9% Sodium Chloride Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter; stainless steel

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

0.9% Sodium Chloride Injection, USP in 1000 mL Single Dose Flexible Container, Hospira, Inc., Lake Forest, IL 60045 USA --- NDC# 0409-7983-09

Affected NDC 0409-7983-09

Compare with the code on your package — it is the most precise check available.

Recalling firm
ICU Medical Inc
NDC code
0409-7983-09
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1091-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by ICU Medical Inc

All 2017 recalls
Class I · High risk

POTASSIUM CHLORIDE Inj.

Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq

Ongoing Labeling / mix-up ICU Medical, Inc. NDC 0990-7074-26 D-0268-2025
Class I · High risk

POTASSIUM CHLORIDE Inj.

Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container.

Ongoing Labeling / mix-up ICU Medical, Inc. NDC 0990-7075-26 D-0267-2025

Other particulate / foreign matter recalls from 2017

All particulate / foreign matter recalls
Class III · Low risk

Auryxia (ferric citrate)

Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.

Terminated Particulate / foreign matter Keryx Biopharmaceuticals, Inc. NDC 59922-631-01 D-0133-2018